您的购物车当前为空
BRD5529 is a selective inhibitor of CARD9-E3 ubiquitin ligase TRIM62 protein-protein interaction (IC50: 8.6 μM). BRD5529 directly and selectively binds CARD9, disrupts TRIM62 recruitment, inhibits TRIM62-mediated ubiquitinylation, and activation of CARD9.


为众多的药物研发团队赋能,
让新药发现更简单!
BRD5529 is a selective inhibitor of CARD9-E3 ubiquitin ligase TRIM62 protein-protein interaction (IC50: 8.6 μM). BRD5529 directly and selectively binds CARD9, disrupts TRIM62 recruitment, inhibits TRIM62-mediated ubiquitinylation, and activation of CARD9.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 554 | 5日内发货 | |
| 5 mg | ¥ 913 | 6-8周 | |
| 10 mg | ¥ 1,560 | 6-8周 | |
| 100 mg | ¥ 6,990 | 6-8周 | |
| 1 mL x 10 mM (in DMSO) | ¥ 938 | 6-8周 |
BRD5529 相关产品
| 产品描述 | BRD5529 is a selective inhibitor of CARD9-E3 ubiquitin ligase TRIM62 protein-protein interaction (IC50: 8.6 μM). BRD5529 directly and selectively binds CARD9, disrupts TRIM62 recruitment, inhibits TRIM62-mediated ubiquitinylation, and activation of CARD9. |
| 靶点活性 | CARD9-TRIM62:8.6 μM |
| 分子量 | 465.54 |
| 分子式 | C25H31N5O4 |
| CAS No. | 1358488-78-4 |
| 密度 | 1.327 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容